Toll Free: 1-888-928-9744
Published: May, 2014 | Pages:
42 | Publisher: Global Markets Direct
Industry: Pharmaceutical | Report Format: Electronic (PDF)
NPS Pharmaceuticals, Inc. - Product Pipeline Review - 2014 Summary Global Markets Direct's, 'NPS Pharmaceuticals, Inc. - Product Pipeline Review - 2014', provides an overview of the NPS Pharmaceuticals, Inc.'s pharmaceutical research and development focus. This report provides comprehensive information on the current therapeutic developmental pipeline of NPS Pharmaceuticals, Inc.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects. Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis. The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products. Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease. Scope - The report provides brief overview of NPS Pharmaceuticals, Inc. including business description, key information and facts, and its locations and subsidiaries - The report reviews current pipeline of NPS Pharmaceuticals, Inc.'s human therapeutic division and enlists all their major and minor projects - The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones - Special feature on out-licensed and partnered product portfolio - The report summarizes all the dormant and discontinued pipeline projects - Latest company statement - Latest news and deals relating to the NPS Pharmaceuticals, Inc.'s pipeline products Reasons to buy - Evaluate NPS Pharmaceuticals, Inc.'s strategic position with total access to detailed information on its product pipeline - Assess the growth potential of NPS Pharmaceuticals, Inc. in its therapy areas of focus - Identify new drug targets and therapeutic classes in the NPS Pharmaceuticals, Inc.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas - Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps - Develop strategic initiatives by understanding the focus areas of NPS Pharmaceuticals, Inc. and exploit collaboration and partnership opportunities - Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage - Plan mergers and acquisitions effectively by identifying the most promising pipeline of NPS Pharmaceuticals, Inc. - Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope - Explore the dormant and discontinued projects of NPS Pharmaceuticals, Inc. and identify potential opportunities in those areas - Avoid Intellectual Property Rights related issues
Table of Contents Table of Contents 2 List of Tables 4 List of Figures 4 NPS Pharmaceuticals, Inc. Snapshot 5 NPS Pharmaceuticals, Inc. Overview 5 Key Information 5 Key Facts 5 NPS Pharmaceuticals, Inc. - Research and Development Overview 6 Key Therapeutic Areas 6 NPS Pharmaceuticals, Inc. - Pipeline Review 8 Pipeline Products by Stage of Development 8 Pipeline Products - Monotherapy 9 Pipeline Products - Out-Licensed Products 10 Out-Licensed Products/Combination Treatment Modalities 11 NPS Pharmaceuticals, Inc. - Pipeline Products Glance 12 NPS Pharmaceuticals, Inc. - Late Stage Pipeline Products 12 Pre-Registration Products/Combination Treatment Modalities 12 Phase III Products/Combination Treatment Modalities 13 NPS Pharmaceuticals, Inc. - Clinical Stage Pipeline Products 14 Phase II Products/Combination Treatment Modalities 14 Phase I Products/Combination Treatment Modalities 15 NPS Pharmaceuticals, Inc. - Early Stage Pipeline Products 16 Preclinical Products/Combination Treatment Modalities 16 NPS Pharmaceuticals, Inc. - Drug Profiles 17 cinacalcet hydrochloride 17 Product Description 17 Mechanism of Action 17 R&D Progress 17 human recombinant parathyroid hormone 19 Product Description 19 Mechanism of Action 19 R&D Progress 19 teduglutide 22 Product Description 22 Mechanism of Action 22 R&D Progress 22 NPSP-790 24 Product Description 24 Mechanism of Action 24 R&D Progress 24 NPSP-795 25 Product Description 25 Mechanism of Action 25 R&D Progress 25 NPS Pharmaceuticals, Inc. - Pipeline Analysis 26 NPS Pharmaceuticals, Inc. - Pipeline Products by Target 26 NPS Pharmaceuticals, Inc. - Pipeline Products by Route of Administration 27 NPS Pharmaceuticals, Inc. - Pipeline Products by Molecule Type 28 NPS Pharmaceuticals, Inc. - Pipeline Products by Mechanism of Action 29 NPS Pharmaceuticals, Inc. - Recent Pipeline Updates 30 NPS Pharmaceuticals, Inc. - Dormant Projects 37 NPS Pharmaceuticals, Inc. - Discontinued Pipeline Products 38 Discontinued Pipeline Product Profiles 38 ALX-0646 38 isovaleramide 38 NPS Pharmaceuticals, Inc. - Company Statement 39 NPS Pharmaceuticals, Inc. - Locations And Subsidiaries 40 Head Office 40 Other Locations & Subsidiaries 40 Appendix 41 Methodology 41 Coverage 41 Secondary Research 41 Primary Research 41 Expert Panel Validation 41 Contact Us 42 Disclaimer 42
List of Tables NPS Pharmaceuticals, Inc., Key Information 5 NPS Pharmaceuticals, Inc., Key Facts 5 NPS Pharmaceuticals, Inc. - Pipeline by Indication, 2014 7 NPS Pharmaceuticals, Inc. - Pipeline by Stage of Development, 2014 8 NPS Pharmaceuticals, Inc. - Monotherapy Products in Pipeline, 2014 9 NPS Pharmaceuticals, Inc. - Out-Licensed Products in Pipeline, 2014 10 NPS Pharmaceuticals, Inc. - Out-Licensed Products/ Combination Treatment Modalities, 2014 11 NPS Pharmaceuticals, Inc. - Pre-Registration, 2014 12 NPS Pharmaceuticals, Inc. - Phase III, 2014 13 NPS Pharmaceuticals, Inc. - Phase II, 2014 14 NPS Pharmaceuticals, Inc. - Phase I, 2014 15 NPS Pharmaceuticals, Inc. - Preclinical, 2014 16 NPS Pharmaceuticals, Inc. - Pipeline by Target, 2014 26 NPS Pharmaceuticals, Inc. - Pipeline by Route of Administration, 2014 27 NPS Pharmaceuticals, Inc. - Pipeline by Molecule Type, 2014 28 NPS Pharmaceuticals, Inc. - Pipeline Products by Mechanism of Action, 2014 29 NPS Pharmaceuticals, Inc. - Recent Pipeline Updates, 2014 30 NPS Pharmaceuticals, Inc. - Dormant Developmental Projects,2014 37 NPS Pharmaceuticals, Inc. - Discontinued Pipeline Products, 2014 38 NPS Pharmaceuticals, Inc., Subsidiaries 40
Speak to the report author to design an exclusive study to serve your research needs.
Your personal and confidential information is safe and secure.